RecallGuardianCanada
Drugs· Updated February 18, 2003

Archived - New contraindications for medications containing ergotamine and dihydroergotamine by Novartis Pharmaceuticals Canada Inc. - Consumer Information - For the Public

Critical priority
Where it was sold

ON, QCReported in the official notice — confirm there.

Issued by

Health Canada — Marketed health products

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls